 |
|
| Blog results | Results 1 - 10 of about 2,126 for capecitabine and oxaliplatin. (0.16 seconds) |
| Sorted by relevance Sort by date |
| 29 Oct 2009 RATIONALE: Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cel... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 24 Nov 2009 The National Institute for Health and Clinical Excellence has issued an appraisal consultation document on the use of bevacizumab in combination with oxaliplatin and either 5-fluorouracil or capecitabine for the treatment of metastatic ... NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/ [ More results from NeLM - News ] |
| 27 Nov 2009 Avastin has been shown to shrink tumours in 78% of patients when used in conjunction with chemotherapy drugs capecitabine and oxaliplatin, while trials have demonstrated that adding Avastin to oxaliplatin-based chemotherapy bolsters ... thepharmaletter.com - http://www.thepharmaletter.com/ |
| 25 Apr 2006 Capecitabine and oxaliplatin are recommended as possible adjuvant treatments after surgery for stage III (Dukes' C) colon cancer, when used in the following ways: capecitabine on its own oxaliplatin together with 5-fluorouracil and ... NICE | Published appraisals - http://www.nice.org.uk/page.aspx?o=appraisals.completed |
| 29 Nov 2009 The bevacizumab-based drug has been shown to shrink tumours in 78% of patients when added to chemotherapy drugs capecitabine and oxaliplatin. It was rejected by NICE even after Roche had offered a patient-access scheme to reduce the ... Pharmacy Europe - http://www.pharmacyeurope.net/rss.asp |
| 24 Nov 2009 by Kamilah Qasimi At the cost of nearly 1800 Pounds a month, Avastin has been found effective in shrinking tumors in 78% of the patients it was initially tested on, with a combination of chemotherapy drugs capecitabine and oxaliplatin. ... TopNews Arab Emirates - http://topnews.ae/ - References |
| 16 Oct 2009 Eric Van Cutsem, MD, of the University Hospital Gasthuisberg, Leuven, Belgium, agreed that it may be best not to recommend combining cetuximab with capecitabine and oxaliplatin until more data are available but that he would definitely ... Cancer Network - http://www.cancernetwork.com/ [ More results from Cancer Network ] |
| 29 Nov 2009 by Pau Cuevas Preliminary recommendations published this week estimated that Avastin plus XELOX (capecitabine, oxaliplatin) as a first-line CRC treatment produced an incremental cost effectiveness ratio (ICER) of GBP36,400 per QALY compared to XELOX ... PipelineReview.com News Channe () - http://www.pipelinereview.com/ |
| 2 Jan 2008 by Cunningham, D., Starling, N., Rao, S.,... Original Article from The New England Journal of Medicine -- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer. NEJM - Articles - http://content.nejm.org/ - References [ More results from NEJM - Articles ] |
| 14 May 2009 Participate in a clinical trial for metastic esophagogastric adenocarcinomas. DukeHealth.org: Duke Clinical Trials - http://www.dukehealth.org/?utm_source=dukehealth.org&utm_m... [ More results from DukeHealth.org: Duke Clinical Trials ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
